These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of altered RTN3 expression on BACE1 activity and Alzheimer's neuritic plaques. Sharoar MG; Yan R Rev Neurosci; 2017 Feb; 28(2):145-154. PubMed ID: 27883331 [TBL] [Abstract][Full Text] [Related]
5. Localization and Trafficking of Amyloid-β Protein Precursor and Secretases: Impact on Alzheimer's Disease. Agostinho P; Pliássova A; Oliveira CR; Cunha RA J Alzheimers Dis; 2015; 45(2):329-47. PubMed ID: 25589722 [TBL] [Abstract][Full Text] [Related]
6. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease. Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246 [TBL] [Abstract][Full Text] [Related]
9. CD147, a gamma-secretase associated protein is upregulated in Alzheimer's disease brain and its cellular trafficking is affected by presenilin-2. Nahalkova J; Volkmann I; Aoki M; Winblad B; Bogdanovic N; Tjernberg LO; Behbahani H Neurochem Int; 2010 Jan; 56(1):67-76. PubMed ID: 19751784 [TBL] [Abstract][Full Text] [Related]
10. Secretases-related miRNAs in Alzheimer's disease: new approach for biomarker discovery. Hajjari SN; Mehdizadeh M; Sadigh-Eteghad S; Shanehbandi D; Teimourian S; Baradaran B Neurol Sci; 2017 Nov; 38(11):1921-1926. PubMed ID: 28791490 [TBL] [Abstract][Full Text] [Related]
11. Update on amyloid-beta homeostasis markers for sporadic Alzheimer's disease. Zetterberg H Scand J Clin Lab Invest; 2009; 69(1):18-21. PubMed ID: 19199126 [TBL] [Abstract][Full Text] [Related]
12. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease. Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531 [TBL] [Abstract][Full Text] [Related]
13. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease. Shackleton B; Crawford F; Bachmeier C Curr Alzheimer Res; 2017; 14(6):578-585. PubMed ID: 28164773 [TBL] [Abstract][Full Text] [Related]
15. Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression". Lee HG; Perry G; Zhu X; Nunomura A; Smith MA Free Radic Biol Med; 2006 Jul; 41(2):188-9. PubMed ID: 16814097 [No Abstract] [Full Text] [Related]
16. Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase. Yang H; Zhuo JM; Chu J; Chinnici C; Praticò D Biol Psychiatry; 2010 Nov; 68(10):922-9. PubMed ID: 20570249 [TBL] [Abstract][Full Text] [Related]
17. The FAM3 superfamily member ILEI ameliorates Alzheimer's disease-like pathology by destabilizing the penultimate amyloid-β precursor. Hasegawa H; Liu L; Tooyama I; Murayama S; Nishimura M Nat Commun; 2014 Jun; 5():3917. PubMed ID: 24894631 [TBL] [Abstract][Full Text] [Related]
18. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production. Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates. Mitani Y; Akashiba H; Saita K; Yarimizu J; Uchino H; Okabe M; Asai M; Yamasaki S; Nozawa T; Ishikawa N; Shitaka Y; Ni K; Matsuoka N Neuropharmacology; 2014 Apr; 79():412-9. PubMed ID: 24373902 [TBL] [Abstract][Full Text] [Related]